期刊文献+

表皮生长因子受体-酪氨酸激酶抑制剂对非小细胞肺癌患者中枢神经系统转移的疗效 被引量:6

原文传递
导出
摘要 肺癌是目前世界上导致肿瘤相关死亡的首要原因,严重威胁着人类的健康,其中非小细胞肺癌(NSCLC)占70%-80%,且80%的NSCLC患者在诊断时已处于疾病晚期(Ⅲb~Ⅳ期)。脑转移是晚期NSCLC常见的转移部位,约10%-25%的患者诊断时已出现中枢神经系统(CNS)转移,在治疗中,40%-50%的患者出现CNS转移。CNS转移主要包括脑转移和脑膜转移,通常表现为颅内压增高,如恶心、呕吐及头痛等;脑转移的部位通常位于脑白质和灰质交界区,
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2014年第3期169-171,共3页 Chinese Journal of Tuberculosis and Respiratory Diseases
作者简介 通信作者:王孟昭,Email:mengzhaowang@sina.com
  • 相关文献

参考文献2

二级参考文献17

  • 1Arrieta O,Saavedra-Perez D,Kuri R,et al. Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer:a prospective analysis.BMC Cancer,2009,9:119.
  • 2Chen AM,Jahan TM,Jablons DM,et al. Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer:clinical implications for the subsequent management of the brain.Cancer,2007,109:1668-1675.
  • 3Siker ML,Mehta ME Resection versus radiosurgery for patients with brain metastases.Future Oncol,2007,3:95-102.
  • 4Ma S,Xu Y,Deng Q,et al.Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib in a Chinese population.Lung Cancer,2009,65:198-203.
  • 5Kim JE,Lee DH,Cboi Y,et al.Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis.Lung Cancer,2009,65:351-354.
  • 6Therasse P,Arbuck SG,Eisenhauer EA,et al.New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States,National Cancer Institute of Canada.J Nail Cancer Inst,2000,92:205-216.
  • 7Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0:development of a comprehensive grading system for the adverse effects of cancer treatment.Semin Radiat Oncol,2003,13:176-181.
  • 8Thatcher N,Chang A,Parikh P,et al. Gefitinib plus best supportive care in previously treated patients with refractory and advanced non-small-cell lung cancer:results from a randomised,placebo-controlled,multicentre study (Iressa Survival Evaluation in Lung Cancer).Lancet,2005,366:1527-1537.
  • 9Kim MK,Lee KH,Lee JK,et al. Gefitinib is also active for carcinomatous meningitis in NSCLC. Lung Cancer,2005,50:265-269.
  • 10Namba Y,Kijima T,Yokota S,et al.Gefitinib in patients with brain metastases from non-small-cell lung cancer:review of 15 clinical cases.Clin Lung Cancer,2004,6:123-128.

共引文献56

同被引文献57

  • 1徐永峰,周启臻.肺癌脑转移16例手术治疗[J].中国煤炭工业医学杂志,2005,8(5):513-513. 被引量:2
  • 2陈灏珠.实用内科学:下册[M].14版.北京:人民卫生出版社,2013:1819.
  • 3Liu R, Wang X, Ma B, et al. Concomitant or adjuvanttemozolomide with whole-brain irradiation for brain metastases: ameta-analysis [ J ]. Anti- cancer Drugs,2010,21 : 120-128.
  • 4彭玉珍.以脑转移为首发表现的肺癌15例误诊分析[J].临床误诊误治,1999,12(2):105.
  • 5Kim SH, Lee JE, Yang SH, et al. Induction of cytokines and growth fac- tors by rapamycin in the microenvironment of brain metastases of lung cancer [ J ]. Oncol Lett,2013,5 ( 3 ) :953-958.
  • 6张永奎,竺王玉,何剑营,等.舟山海岛地区非小细胞肺癌EGFR基因19和21外显子突变与临床病理特征的关系[C].2012.
  • 7Huang Z,Wang Y,Nayak PS,et al.Stretch-induced fetal type II cell differentiation is mediated via ErbBErbB4interactions,”e[J].Journal of Biological Chemistry,2012,287,(22):18091-18102.
  • 8Kumar A,Kumar M,Jaiswal R,et al.Presence of Human papilloma virus and EGFR expression does not predict response to Neoadjuvant chemotherapy in oral cancer[J].World Journal of Surgical Medical&Radiation Oncology,2012,1(20):103-110.
  • 9Gloria-Bottini F,Lucarelli P,Saccucci P,et al.Genetic polymorphism and idiopathic generalized epilepsy.Evidence of interaction between haptoglobin and ACP1 systems[J].Neuropediatrics,2009,39(6):357-358.
  • 10陆新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:215-218.

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部